I would say that our closest counterpart is the U.S. They seem to be more open to looking at newer data that's not standardized randomized control trials. They seem to be more proactive. We tend to be very reactive with our guidelines. I think they are more innovative in terms of looking towards changes that could be made. I think they would be—
On December 6th, 2023. See this statement in context.